
Dr Reddy’s Q3 profit falls 14 pc to Rs 1,210 crore
Mumbai, Jan 21 (IANS) Dr Reddy's Laboratories on Wednesday reported a 14 per cent decline in its consolidated net profit for the December quarter (Q3) of FY26.The drugmaker said its consolidated net profit fell 14 per cent year-on-year (YoY) to Rs 1,209.8 crore in Q3 FY26, compared with Rs 1,413.3 crore in the same quarter last financial year, according to its stock exchange filing.Revenue from operations during the quarter rose 4.4 per cent to Rs 8,726.8 crore, up from Rs 8,358.6 crore in the year-ago period, supported by growth across most key markets.On the operating front, EBITDA declined 10.8 per cent year-on-year to Rs 2,049.3 crore.The company’s gross margins also came under pressure, easing to 53.6 per cent in Q3 FY26 from 58.7 per cent in Q3 FY25 and 54.7 per cent in the previous ...









